InspireMD (NSPR) News Today $2.36 -0.07 (-2.88%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.42 +0.06 (+2.54%) As of 07/11/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NSPR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period InspireMD stock rises after US commercial launch of carotid stent systemJuly 10 at 4:16 AM | au.investing.comInspireMD Shares Rise on U.S. Rollout of CGuard Prime Carotid StentJuly 10 at 4:16 AM | msn.comInspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of StrokeJuly 9 at 7:00 AM | globenewswire.comInspireMD, Inc. (NSPR) Latest Stock News & Headlines - Yahoo FinanceJuly 5, 2025 | finance.yahoo.comHuntleigh Advisors Inc. Makes New $316,000 Investment in InspireMD, Inc. (NYSE:NSPR)July 5, 2025 | marketbeat.comInspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke - MorningstarJune 26, 2025 | morningstar.comMInspireMD Inc.: InspireMD Announces FDA Approval for CGuard Prime Carotid Stent System for the Prevention of StrokeJune 25, 2025 | finanznachrichten.deInspireMD Stock Surges on FDA Approval for CGuard StentJune 24, 2025 | marketwatch.comInspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of StrokeJune 24, 2025 | globenewswire.comInspireMD Announces CE Mark Approval For CGuard Prime Embolic Prevention SystemJune 15, 2025 | nasdaq.comInspireMD, Inc. Secures CE Mark Approval for CGuard® Prime EPS Carotid Stent SystemJune 15, 2025 | nasdaq.comInspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of StrokeJune 13, 2025 | globenewswire.comInspireMD Hires New Financial ChiefJune 4, 2025 | marketwatch.comInspireMD appoints Michael Lawless CFOJune 4, 2025 | msn.comInspireMD Announces Appointment of Michael Lawless as Chief Financial OfficerJune 3, 2025 | globenewswire.comParkman Healthcare Partners LLC Has $2.25 Million Stock Holdings in InspireMD, Inc. (NYSE:NSPR)May 16, 2025 | marketbeat.comInspireMD at Bank of America 2025: Carotid Stent InnovationMay 15, 2025 | uk.investing.comPiper Sandler Lowers InspireMD (NYSE:NSPR) Price Target to $4.00May 14, 2025 | marketbeat.comEarnings call transcript: InspireMD Q1 2025 shows mixed resultsMay 11, 2025 | uk.investing.comInspireMD, Inc. Reports Q1 2025 Financial Results and Anticipates FDA Approval for CGuard™ Prime Carotid Stent SystemMay 11, 2025 | nasdaq.comInspireMD, Inc. (NASDAQ:NSPR) Q1 2025 Earnings Call TranscriptMay 10, 2025 | insidermonkey.comInspireMD Inc.: InspireMD Reports First Quarter 2025 Financial ResultsMay 9, 2025 | finanznachrichten.deINSPIREMD Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and MoreMay 9, 2025 | nasdaq.comInspireMD Q1 2025 Earnings PreviewMay 9, 2025 | msn.com4NSPR : A Look Ahead: InspireMD's Earnings ForecastMay 9, 2025 | benzinga.comInspireMD, Inc. (NSPR) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comInspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is OptimisticMay 9, 2025 | msn.comInspireMD Reports First Quarter 2025 Financial ResultsMay 9, 2025 | globenewswire.comInspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.comMay 6, 2025 | marketbeat.comInspireMD to Present at Upcoming Bank of America 2025 Healthcare ConferenceApril 30, 2025 | globenewswire.comNantahala Capital Management LLC Trims Stock Holdings in InspireMD, Inc. (NYSE:NSPR)April 30, 2025 | marketbeat.comInspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.comApril 28, 2025 | marketbeat.comInspireMD to Announce First Quarter 2025 Financial ResultsApril 25, 2025 | globenewswire.comStockNews.com Begins Coverage on InspireMD (NYSE:NSPR)April 20, 2025 | marketbeat.comStockNews.com Initiates Coverage on InspireMD (NYSE:NSPR)April 13, 2025 | marketbeat.comInspireMD Inc.: InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 8, 2025 | finanznachrichten.deInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 8, 2025 | globenewswire.comInspireMD files $200M mixed securities shelfApril 2, 2025 | markets.businessinsider.comInspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare ConferenceMarch 26, 2025 | globenewswire.comInspireMD (NYSE:NSPR) Coverage Initiated at StockNews.comMarch 26, 2025 | marketbeat.comInspireMD, Inc. (NASDAQ:NSPR) Q4 2024 Earnings Call TranscriptMarch 14, 2025 | msn.comInspireMD, Inc. (NSPR) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comInspireMD reports Q4 EPS (19c) vs (16c) last yearMarch 12, 2025 | markets.businessinsider.comInspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue EstimatesMarch 12, 2025 | msn.comInspireMD Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 12, 2025 | globenewswire.comNuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates (Revised)March 11, 2025 | msn.comLake Street Remains a Buy on InspireMD (NSPR)March 10, 2025 | markets.businessinsider.comInspireMD (NYSE:NSPR) Now Covered by StockNews.comMarch 2, 2025 | marketbeat.comNSPR stock touches 52-week high at $3.43 amid robust growthFebruary 26, 2025 | investing.comInspireMD to Announce Fourth Quarter and Full Year 2024 Financial ResultsFebruary 26, 2025 | globenewswire.com Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address NSPR Media Mentions By Week NSPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NSPR News Sentiment▼0.541.00▲Average Medical News Sentiment NSPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NSPR Articles This Week▼42▲NSPR Articles Average Week Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNWV News Today DRTS News Today NYXH News Today SMTI News Today CATX News Today BWAY News Today TCMD News Today NVRO News Today STIM News Today SGHT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NSPR) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InspireMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
